These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8300642)

  • 1. Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells.
    Herbert JM; Lamarche I; Prabonnaud V; Dol F; Gauthier T
    J Biol Chem; 1994 Jan; 269(4):3076-80. PubMed ID: 8300642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation.
    Xiaoli M; Wenying H; Mingpeng S
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S57-64; discussion S65. PubMed ID: 9951803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells.
    Herbert JM; Lamarche I; Carmeliet P
    J Biol Chem; 1997 Sep; 272(38):23585-91. PubMed ID: 9295297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis.
    Au YP; Kenagy RD; Clowes AW
    J Biol Chem; 1992 Feb; 267(5):3438-44. PubMed ID: 1310687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
    Weber H; Taylor DS; Molloy CJ
    J Clin Invest; 1994 Feb; 93(2):788-98. PubMed ID: 7509348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
    Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
    Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 impairs plasminogen activation-mediated vascular smooth muscle cell apoptosis.
    Rossignol P; Anglès-Cano E; Lijnen HR
    Thromb Haemost; 2006 Nov; 96(5):665-70. PubMed ID: 17080225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lead perturbs the regulation of spontaneous release of tissue plasminogen activator and plasminogen activator inhibitor-1 from vascular smooth muscle cells and fibroblasts in culture.
    Yamamoto C; Miyamoto A; Sakamoto M; Kaji T; Kozuka H
    Toxicology; 1997 Feb; 117(2-3):153-61. PubMed ID: 9057894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
    Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
    Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
    van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
    Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
    Reuning U; Bang NU
    Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cadmium on the release of tissue plasminogen activator and plasminogen activator inhibitor type 1 from cultured human vascular smooth muscle cells and fibroblasts.
    Yamamoto C; Kaji T; Sakamoto M; Kozuka H
    Toxicology; 1996 Jan; 106(1-3):179-85. PubMed ID: 8571389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of u-PA in the anti-apoptotic activity of TGFbeta for vascular smooth muscle cells.
    Herbert JM; Carmeliet P
    FEBS Lett; 1997 Aug; 413(3):401-4. PubMed ID: 9303544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.
    De Petro G; Copeta A; Barlati S
    Exp Cell Res; 1994 Jul; 213(1):286-94. PubMed ID: 8020601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effect of heparin for vascular smooth muscle cell proliferation or migration is not mediated by u-PA and t-PA.
    Herbert JM; Bono F; Lamarche I; Carmeliet P
    Thromb Res; 1997 May; 86(4):317-24. PubMed ID: 9187019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor increases plasminogen activator inhibitor-1 activity and mRNA in rat cultured vascular smooth muscle.
    Sperti G; van Leeuwen R; Maseri A; Kluft C
    Ann N Y Acad Sci; 1992 Dec; 667():178-80. PubMed ID: 1309033
    [No Abstract]   [Full Text] [Related]  

  • 17. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion.
    Okada SS; Grobmyer SR; Barnathan ES
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1269-76. PubMed ID: 8857924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.
    McNamara CA; Sarembock IJ; Gimple LW; Fenton JW; Coughlin SR; Owens GK
    J Clin Invest; 1993 Jan; 91(1):94-8. PubMed ID: 8380817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
    Ueshima S; Fukao H; Okada K; Matsuo O
    Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of catecholamine-induced proliferation of vascular smooth muscle cells.
    Yu SM; Tsai SY; Guh JH; Ko FN; Teng CM; Ou JT
    Circulation; 1996 Aug; 94(3):547-54. PubMed ID: 8759101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.